Legend Biotech (NASDAQ:LEGN – Get Rating) had its price objective boosted by investment analysts at HC Wainwright from $77.00 to $82.00 in a report released on Tuesday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 20.23% from the stock’s current price. Several other equities analysts have also recently issued reports […]
William Blair initiated coverage on shares of Legend Biotech (NASDAQ:LEGN – Get Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage issued a market perform rating and a $64.00 price target on the stock. LEGN has been the topic of several other research reports. Barclays boosted their price target […]
William Blair started coverage on shares of Legend Biotech (NASDAQ:LEGN – Get Rating) in a report released on Thursday morning, The Fly reports. The brokerage issued a market perform rating and a $64.00 price target on the stock. Other equities research analysts also recently issued research reports about the company. HC Wainwright boosted their price […]
Daiwa Capital Markets initiated coverage on shares of Legend Biotech (NASDAQ:LEGN – Get Rating) in a research report sent to investors on Monday morning, The Fly reports. The firm issued a buy rating on the stock. A number of other equities analysts have also recently commented on LEGN. Barclays boosted their price target on Legend […]
William Blair began coverage on shares of Legend Biotech (NASDAQ:LEGN – Get Rating) in a report issued on Thursday, The Fly reports. The firm issued a market perform rating and a $64.00 price target on the stock. Other equities research analysts have also issued reports about the company. HC Wainwright upped their price target on […]